Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Anticancer Activity of Limonia acidissima Linn (Rutaceae) Fruit Extracts on Human Breast Cancer Cell Lines

Debasish Pradhan¹ , Gitanjali Tripathy¹, Santosh Patanaik²

¹University Department of Pharmaceutical Sciences, Utkal University, Orissa751004; ²All India Institute of Medical Sciences, New Delhi-01, India.

For correspondence:- Debasish Pradhan Email: debaudps@yahoo.co.in Tel:+9861137772

Received: 8 October 2011 Accepted: 28 April 2012 Published: 15 June 2012

Citation: Pradhan D, Tripathy G, Patanaik S. Anticancer Activity of Limonia acidissima Linn (Rutaceae) Fruit Extracts on Human Breast Cancer Cell Lines. Trop J Pharm Res 2012; 11(3):413-419 doi: 10.4314/tjpr.v11i3.10

© 2012 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To evaluate the anti-cancer activity of Limonia acidissima Linn (Rutaceae) which has long been used traditionally for various infectious and malignant diseases.

Methods: The fruit extract of Limonia acidissima Linn was obtained by macerating 3 times with methanol and then concentrating it at reduced pressure. Bioassay of the extract was carried out to assess the anticancer activity. Breast cancer cell lines, SKBR3 and MDA MB435, were used for in-vitro cell proliferation, cell viability assay, and cell cycle analysis of the extract.

Results: Bioassay of the extract of Limonia acidissima Linn. showed that a fraction (fraction 3) of the ethanol extract had anticancer activity against SKBR3 and MDA-MB435 human breast cancer cells. The effective dose (ED₅₀) of Limonia acidissima Linn. fraction 3 was 56.1 and 30.6 μg/ml for SKBR3 and MDA-MB435, respectively. After 48 h of exposure, this fraction (100 μg/ml) significantly reduced cell proliferation in both cancer cell lines. In MDA-MB435 cells, cell cycle analysis showed that fraction 3 induced the accumulation of cells in G2/M phase, but no significant change in cell cycle was detected in SKBR3 cells.

Conclusion: The results indicate that the extract fraction could induce cell cycle arrest. However, further investigation is needed to assess the molecular mechanisms of the anticancer activities of this plant.

Keywords: Anticancer antivity, Breast cancer cell lines, Limonia acidissima Linn. , G2/M arrest